COVID-24

Session information

General Presentation

基礎ウイルス学

[G5] 一般演題5(基礎ウイルス学2)

Sat. Aug 3, 2024 10:30 AM - 12:18 PM 第1会場 (大ホール)

Chair:Terumasa Ikeda

10:54 AM - 11:06 AM

*Arnon Plianchaisuk1,30、Shigeru Fujita1,2,30、Sayaka Deguchi3,30、Hayato Ito4,30、Naganori Nao5,6,7,30、Lei Wang8,9,30、Hesham Nasser10,11、Tomokazu Tamura4,5,6、Izumi Kimura1、Yukie Kashima12、Rigel Suzuki4,6、Saori Suzuki4,6、Izumi Kida13、Masumi Tsuda8,9、Yoshitaka Oda8、Rina Hashimoto3、Yukio Watanabe3、Keiya Uriu1,2、Daichi Yamasoba1,14、Ziyi Guo1、Alfredo A Hinay Jr.1、Yusuke Kosugi1,2、Luo Chen1,12、Lin Pan1,12、Yu Kaku1、Hin Chu15、Flora Donati16,17、Sarah Temmam18,19、Marc Eloit18,19、Yuki Yamamoto20、Tetsuharu Nagamoto20、Hiroyuki Asakura21、Mami Nagashima21、Kenji Sadamasu21、Kazuhisa Yoshimura21、Yutaka Suzuki12、The Genotype to Phenotype Japan (G2P-Japan) Consortium、Jumpei Ito1,22、Terumasa Ikeda10、Shinya Tanaka8,9、Keita Matsuno5,6,13,23、Takasuke Fukuhara4,5,6,24,25、Kazuo Takayama3,24、Kei Sato1,2,12,22,26,27,28,29 (1. Division of Systems Virology, Department of Microbiology and Immunology, The Institute of Medical Science, The University of Tokyo, Japan、2. Graduate School of Medicine, The University of Tokyo, Japan、3. Center for iPS Cell Research and Application (CiRA), Kyoto University, Kyoto, Japan、4. Department of Microbiology and Immunology, Faculty of Medicine, Hokkaido University, Japan、5. One Health Research Center, Hokkaido University, Japan、6. Institute for Vaccine Research and Development (IVReD), Hokkaido University, Japan、7. Division of International Research Promotion, International Institute for Zoonosis Control, Hokkaido University, Japan、8. Department of Cancer Pathology, Faculty of Medicine, Hokkaido University, Japan、9. Institute for Chemical Reaction Design and Discovery (WPI-ICReDD), Hokkaido University, Japan、10. Division of Molecular Virology and Genetics, Joint Research Center for Human Retrovirus infection, Kumamoto University, Japan、11. Department of Clinical Pathology, Faculty of Medicine, Suez Canal University, Egypt、12. Graduate School of Frontier Sciences, The University of Tokyo, Japan、13. Division of Risk Analysis and Management, International Institute for Zoonosis Control, Hokkaido University, Japan、14. Faculty of Medicine, Kobe University, Japan、15. State Key Laboratory of Emerging Infectious Diseases, Department of Microbiology, School of Clinical Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, China、16. Institut Pasteur, Université Paris Cité, CNRS UMR 3569, Molecular Genetics of RNA Viruses Unit, France、17. Institut Pasteur, Université Paris Cité, National Reference Center for Respiratory Viruses, France、18. Institut Pasteur, Université Paris Cité, Pathogen Discovery Laboratory, France、19. Institut Pasteur, Université Paris Cité, The WOAH(OIE) Collaborating Center for the Detection and Identification in Humans of Emerging Animal Pathogens, France、20. HiLung Inc., Japan、21. Tokyo Metropolitan Institute of Public Health, Japan、22. International Research Center for Infectious Diseases, The Institute of Medical Science, The University of Tokyo, Japan、23. International Collaboration Unit, International Institute for Zoonosis Control, Hokkaido University, Japan、24. AMED-CREST, Japan Agency for Medical Research and Development (AMED), Japan、25. Laboratory of Virus Control, Research Institute for Microbial Diseases, Osaka University, Japan、26. CREST, Japan Science and Technology Agency, Japan、27. International Vaccine Design Center, The Institute of Medical Science, The University of Tokyo, Japan、28. Collaboration Unit for Infection, Joint Research Center for Human Retrovirus infection, Kumamoto University, Japan、29. MRC-University of Glasgow Centre for Virus Research, UK、30. These authors contributed equally.)

11:06 AM - 11:18 AM

*矢島 久乃1、安楽 佑樹2、名倉 淑子1、木村 香菜子1、喜多 俊介2、佐々木 慈英1、佐藤 佳3、前仲 勝実2、橋口 隆生1 (1. 京都大学医生物学研究所ウイルス制御分野、2. 北海道大学薬学研究院生体分子機能学研究室、3. 東京大学医科学研究所システムウイルス学分野)

11:18 AM - 11:30 AM

*宮﨑 かや1,2、志和(須藤) 希3、岩田(吉河) 奈織子3、坂井 祐介3、鈴木 忠樹3、長谷川 秀樹1,2、永田 典代3 (1. 国立感染症研究所 インフルエンザ・呼吸器系ウイルス研究センター 、2. 東北大学大学院 医学系研究科 感染症病理学分野、3. 国立感染症研究所 感染病理部)

11:42 AM - 11:54 AM

*辻野 修平1、田村 友和1,2,3、高山 和雄4、佐藤 佳5、田中 伸哉6、松野 啓太7、福原 崇介1,2,3,8 (1. 北海道大学大学院医学研究病原微生物学教室、2. 北海道大学OneHealthリサーチセンター、3. 北海道大学創成研究機構ワクチン開発拠点、4. 京都大学iPS細胞研究所、5. 東京大学医科学研究所、6. 北海道大学大学院医学研究院腫瘍病理学教室、7. 北海道大学人獣共通感染症国際共同研究所、8. 大阪大学微生物病研究所)

11:54 AM - 12:06 PM

*Michael Jonathan1,2、Monira Begum1、Ichihara Kimiko1、Takahashi Otowa1、Hesham Nasser1、The Genotype to Phenotype Japan (G2P-Japan) Consortium、Sato Kei3、Ikeda Terumasa1 (1. Division of Molecular Virology and Genetics, Joint Research Center for Human Retrovirus Infection, Kumamoto University, Kumamoto, Japan 、2. Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan、3. Division of Systems Virology, Department of Microbiology and Immunity, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan)

×

Authentication

Abstract password authentication.
Password is required to view the abstract. Please enter a password to authenticate.

×

Please log in with your participant account.
» Participant Log In